Biotech Company Profiles

Pioneering CRISPR-based medicines

In vivo CRISPR gene editing

Precision base editing medicines

Gene editing for heart disease

Editing genes to treat disease

Search-and-replace gene editing

Next-gen CRISPR for cell therapy

Restoring cell health to reverse disease

Reversing aging through partial epigenetic reprogramming — first in humans

Adding 10 years to healthy human lifespan

Epigenome editing — gene control without cutting

Programmable RNA editing

Zinc finger pioneers

AI-powered drug discovery for aging

Epigenetic reprogramming for human rejuvenation

mRNA epigenetic reprogramming

De-extinction and species preservation through gene editing

AI-first drug discovery from DeepMind

China's CRISPR and RNA editing leader

Next-gen CRISPR for neurological diseases

Transformer base editing from China

TALEN pioneers for off-the-shelf CAR-T

mRNA giant expanding into gene editing

Tuning genes without cutting DNA

Epigenome editing from Japan

Korea's CRISPR pioneer

Coding biology to reprogram human cells

Shielded cell therapy via gene editing

India's stem cell and gene therapy pioneer

Multi-approach anti-aging therapeutics

Precision AAV gene therapy for the eye, brain, and salivary glands

Gene silencing with DNA-directed RNA interference (ddRNAi)

A portfolio approach to drug aging itself

Precision gene editing with prime editing technology